News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,964 Results
Type
Article (11291)
Company Profile (28)
Press Release (57643)
Multimedia
Podcasts (34)
Webinars (6)
Section
Business (16741)
Career Advice (1644)
Deals (2851)
Drug Delivery (50)
Drug Development (8429)
Employer Resources (111)
FDA (1796)
Job Trends (2176)
News (31698)
Policy (4645)
Tag
Academia (678)
Accelerated approval (6)
Adcomms (13)
Allergies (27)
Alliances (4359)
ALS (28)
Alzheimer's disease (240)
Antibody-drug conjugate (ADC) (52)
Approvals (1738)
Artificial intelligence (99)
Autoimmune disease (12)
Automation (5)
Bankruptcy (48)
Best Places to Work (1611)
BIOSECURE Act (11)
Biosimilars (24)
Biotechnology (21)
Bladder cancer (13)
Brain cancer (9)
Breast cancer (46)
Cancer (469)
Cardiovascular disease (45)
Career advice (1359)
Career pathing (29)
CAR-T (42)
CDC (21)
Cell therapy (130)
Cervical cancer (5)
Clinical research (6411)
Collaboration (173)
Company closure (3)
Compensation (45)
Complete response letters (12)
COVID-19 (771)
CRISPR (21)
C-suite (83)
Cystic fibrosis (15)
Data (518)
Decentralized trials (1)
Denatured (7)
Depression (29)
Diabetes (82)
Diagnostics (667)
Digital health (4)
Diversity (4)
Diversity, equity & inclusion (29)
Drug discovery (44)
Drug pricing (75)
Drug shortages (12)
Duchenne muscular dystrophy (35)
Earnings (4862)
Editorial (47)
Employer branding (11)
Employer resources (102)
Events (7968)
Executive appointments (105)
FDA (2103)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (206)
Gene editing (39)
Generative AI (12)
Gene therapy (129)
GLP-1 (241)
Government (1047)
Grass and pollen (2)
Guidances (31)
Healthcare (2626)
HIV (17)
Huntington's disease (9)
IgA nephropathy (4)
Immunology and inflammation (54)
Immuno-oncology (15)
Indications (2)
Infectious disease (810)
Inflammatory bowel disease (18)
Inflation Reduction Act (5)
Influenza (11)
Intellectual property (17)
Interviews (322)
IPO (1076)
IRA (25)
Job creations (570)
Job search strategy (1109)
Kidney cancer (2)
Labor market (50)
Layoffs (161)
Leadership (29)
Legal (1638)
Liver cancer (13)
Longevity (5)
Lung cancer (62)
Lymphoma (30)
Machine learning (11)
Management (42)
Manufacturing (130)
MASH (18)
Medical device (1278)
Medtech (1281)
Mergers & acquisitions (1854)
Metabolic disorders (256)
Multiple sclerosis (12)
NASH (4)
Neurodegenerative disease (49)
Neuropsychiatric disorders (16)
Neuroscience (404)
NextGen: Class of 2025 (1245)
Non-profit (946)
Now hiring (12)
Obesity (147)
Opinion (213)
Ovarian cancer (9)
Pain (31)
Pancreatic cancer (22)
Parkinson's disease (29)
Partnered (14)
Patents (44)
Patient recruitment (30)
Peanut (6)
People (5446)
Pharmaceutical (4)
Pharmacy benefit managers (9)
Phase I (2139)
Phase II (2782)
Phase III (2320)
Pipeline (325)
Policy (136)
Postmarket research (251)
Preclinical (836)
Press Release (8)
Prostate cancer (25)
Psychedelics (18)
Radiopharmaceuticals (23)
Rare diseases (154)
Real estate (797)
Recruiting (48)
Regulatory (2603)
Reports (8)
Research institute (524)
Resumes & cover letters (288)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (20)
Series A (34)
Series B (26)
Service/supplier (1)
Sickle cell disease (17)
Special edition (10)
Spinal muscular atrophy (18)
Sponsored (13)
Startups (543)
Stomach cancer (4)
Supply chain (17)
Tariffs (46)
The Weekly (27)
Vaccines (267)
Venture capital (39)
Weight loss (133)
Women's health (16)
Worklife (16)
Date
Last 7 days (92)
Last 30 days (303)
Last 365 days (3654)
2025 (3127)
2024 (3719)
2023 (3862)
2022 (4866)
2021 (5707)
2020 (5675)
2019 (6141)
2018 (4817)
2017 (3585)
2016 (3793)
2015 (4185)
2014 (2789)
2013 (2154)
2012 (2397)
2011 (2456)
2010 (1672)
Location
Africa (322)
Alabama (7)
Alaska (1)
Arizona (10)
Arkansas (3)
Asia (3704)
Australia (885)
California (1059)
Canada (260)
China (75)
Colorado (34)
Connecticut (40)
Delaware (30)
Europe (8904)
Florida (116)
Georgia (16)
Idaho (5)
Illinois (73)
India (7)
Indiana (38)
Japan (28)
Kansas (20)
Kentucky (7)
Louisiana (5)
Maine (7)
Maryland (169)
Massachusetts (632)
Michigan (32)
Minnesota (32)
Mississippi (2)
Missouri (9)
Montana (3)
Nebraska (1)
Nevada (6)
New Hampshire (8)
New Jersey (221)
New Mexico (4)
New York (334)
North Carolina (90)
Northern California (419)
Ohio (27)
Oklahoma (4)
Oregon (4)
Pennsylvania (153)
Rhode Island (6)
South America (344)
South Carolina (9)
Southern California (416)
Tennessee (12)
Texas (158)
United States (3384)
Utah (32)
Virginia (24)
Washington D.C. (19)
Washington State (54)
West Virginia (2)
Wisconsin (16)
68,964 Results for "just biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Glioblastomas Affect Much More Than Just the Brain
October 3, 2025
·
6 min read
Press Releases
HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test
October 15, 2025
·
4 min read
Mergers & acquisitions
Just 9.5% of Life Sciences M&A Milestones Have Been Paid Since 2008
A new analysis from SRS Acquiom puts into perspective the headline values seen when a company announces a backloaded M&A deal. Biotechs have much on the line when they agree to deals with massive potential but little upfront.
October 1, 2025
·
2 min read
·
Annalee Armstrong
Layoffs
Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs
This year, Novo Nordisk and Merck announced significant layoffs, with Novo planning to axe about 9,000 employees and Merck projecting it could let go of roughly 6,000. Meanwhile, Bayer, Bristol Myers Squibb, Novartis and Pfizer have also made noteworthy cuts.
September 18, 2025
·
9 min read
·
Angela Gabriel
Press Releases
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
·
6 min read
Press Releases
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November 2025
October 31, 2025
·
3 min read
IN PARTNERSHIP WITH IQVIA
We Don’t Own Patient Data–We’re Just Babysitting It
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the concerns and opportunities of patient data driving AI tasks with Louise Molloy, associate director medical information and pharmacovigilance.
July 31, 2025
·
1 min read
·
Lori Ellis
Regulatory
Drug Pricing Just One Point of Confusion Over New FDA Vouchers
The Commissioner’s National Priority Vouchers aim to offer accelerated pathways to drugs that meet certain criteria, perhaps including a low price-tag. But the policy is vaguely defined and was announced without public input, going against the FDA’s own published practices, experts say.
July 28, 2025
·
4 min read
·
Dan Samorodnitsky
Startups
Longevity Biotechs Strive for Better Aging—Not Just Life Extension
The industry sector focused on aging is only about 10 years old, but acting on what scientists already know, a new crop of biotechs, backed by investors, are taking a disease-centric approach to extending the human lifespan.
July 9, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
·
1 min read
1 of 6,897
Next
